Intravenous Platelet Inhibition in the Catheterization Lab: What, When, and Why?

Faculty and Program

	Suzanne J. Baron, MD, FSCAI Moderator Introduction		Srihari S. Naidu, MD, FSCAI Moderator Cangrelor – Using IV P2Y12 Inhibitor Therapy to Optimize Platelet Inhibition
	Sunil V. Rao, MD, FSCAI What is the Role for G2b3a Inhibitors in the Current Era of PCI?		Katherine Kunkel, MD, FSCAI Pharmacologic Management of Heavy Thrombus Burden in the Cath Lab: Tips, Tricks and Tweaks for the Interventionalist
	Nadia R. Sutton, MD, FSCAI Panelist

Learning Objectives

Upon completion of this activity, participants will be able to:

Review the data supporting the use of IV P2Y12 Inhibitor therapy in the cath lab.
Critically evaluate the role of G2b3a inhibitors in the current era.
Discuss the application of pharmacotherapy in treating high clot burden.

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Chiesi. No in kind commercial support was received.

Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Summary


Availability:	On-Demand


Cost:	FREE


Credit Offered:	No Credit Offered